Sanofi-Aventis to refinance its Eu16bn M&A loan, ultra-tight margin expected
Sanofi-Aventis, the French pharmaceuticals giant, is in talks with banks to refinance the Eu16bn loan that Sanofi-Synthélabo used to support its acquisition of a majority stake in Aventis last year, EuroWeek hears.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: